Catalent
CTLT
#1594
Rank
HK$84.52 B
Marketcap
HK$465.68
Share price
-0.05%
Change (1 day)
71.03%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Net assets

Net assets on the balance sheet as of June 2024 : HK$28.00 Billion

According to Catalent's latest financial reports the company has HK$28.00 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Catalent - Net assets on balance sheet (from 2013 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$HK$36.14 B-3.52%
2022-06-30$HK$37.46 B12.91%
2021-06-30$HK$33.18 B22.11%
2020-06-30$HK$27.17 B51.98%
2019-06-30$HK$17.87 B109.63%
2018-06-30$HK$8.52 B51.05%
2017-06-30$HK$5.64 B14.44%
2016-06-30$HK$4.93 B0.39%
2015-06-30$HK$4.91 B-270.53%
2014-06-30$-HK$2.89 Billion-9.45%
2013-06-30$-HK$3.19 Billion16.98%
2012-06-30$-HK$2.73 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
HK$7.44 B-73.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.28 Billion-104.55%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$29.24 B 4.40%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
HK$0.55 B-98.01%๐Ÿ‡บ๐Ÿ‡ธ USA